Shanghai Kinetic Medical Co., Ltd. announces an Equity Buyback for 12,500,000 shares, representing 1.73% for CNY 150 million.
January 03, 2019
Share
Shanghai Kinetic Medical Co., Ltd. (SZSE:300326) announces a share repurchase program. Under the program, the company will repurchase up to a maximum of 12,500,000 class A shares, representing 1.73% of the issued share capital, for not more than CNY 150 million. The shares will be purchased at a price not exceeding CNY 12 per share. The repurchase program will be funded from company’s own funds or self-raised funds. The repurchased shares will be used for the implementation of equity incentive plan, ESOP or conversion of corporate bonds which are convertible to shares. The repurchase program is valid for a period of 12 months.
Shanghai Kinetic Medical Co., Ltd is a China-based company principally engaged in the research, development, manufacture and sale of minimally invasive surgical systems. The Company is mainly engaged in the research, development, manufacture and sale of minimally invasive interventional surgical systems for vertebroplasty, the research, development, manufacture and sale of orthopedic medical devices, such as orthopedic implants and orthopedic surgical instruments, as well as the development, manufacture and sale of drug-eluting coronary stents. The Company operates its business in domestic market.
SHANGHAI KINETIC MEDICAL CO., LTD 
